NSE · AI Signal & Stock Analysis · Bullish
As of Nov 13 2026, 6:15 AM, AkshayaAI's signal for CONCORDBIO is Bullish ↑ (moderate move); technical trend down-trend; trading at ₹601.80 (+0.77% today); oversold (RSI 20). AkshayaAI's signal, trend and forecast for CONCORDBIO have been unchanged since 5 Nov 2026.
Data as of Nov 13 2026, 6:15 AM. Informational analytics only — not investment advice.
Instant, data-backed answers — free to try.
| AI signal | Bullish ↑ · Moderate move |
|---|---|
| Technical trend | Down-trend (since 2026-09-24) |
| Price | ₹601.80 |
| Change today | +0.77% |
| RSI (14) | 20.00 |
| Relative volume | 1.20 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹12,428 Cr |
| P/E | 44.46 |
| Cap category | Mid Cap |
| 52-week high | -62.1% away |
| 52-week low | +0.8% above |
| Delivery volume | — |
| Sector | Biotechnology |
As of Nov 13 2026, 6:15 AM, AkshayaAI's signal for CONCORDBIO (Concord Biotech Limited) is Bullish with a moderate move, and its technical trend is down-trend. The composite score and full factor breakdown are available to signed-in members.
CONCORDBIO's RSI is oversold (RSI 20). A reading above 70 is typically overbought and below 30 oversold.
CONCORDBIO is trading about 62% below its 52-week high and 1% above its 52-week low as of Nov 13 2026, 6:15 AM.
CONCORDBIO's market capitalisation is ₹12,428 Cr as of Nov 13 2026, 6:15 AM.
CONCORDBIO is classified under Biotechnology in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for CONCORDBIO — not personalised investment advice. Always do your own research.
ANTHEM · BIOCON · BLUEJET · ONESOURCE · SUPRIYA
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Nov 13 2026, 6:15 AM and may not reflect real-time prices. Always do your own research. How these signals work →